A comprehensive diagnostic approach to detect underlying causes of obesity in adults

Obesity is a worldwide growing problem. When confronted with obesity, many health care providers focus on direct treatment of the consequences of adiposity. We plead for adequate diagnostics first, followed by an individualized treatment. We provide experience‐based and evidence‐based practical recommendations (illustrated by clinical examples), to detect potential underlying diseases and contributing factors. Adult patients consulting a doctor for weight gain or obesity should first be clinically assessed for underlying diseases, such as monogenetic or syndromic obesity, hypothyroidism, (cyclic) Cushing syndrome, polycystic ovarian syndrome (PCOS), hypogonadism, growth hormone deficiency, and hypothalamic obesity. The most important alarm symptoms for genetic obesity are early onset obesity, dysmorphic features/congenital malformations with or without intellectual deficit, behavioral problems, hyperphagia, and/or striking family history. Importantly, also common contributing factors to weight gain should be investigated, including medication (mainly psychiatric drugs, (local) corticosteroids, insulin, and specific β‐adrenergic receptor blockers), sleeping habits and quality, crash diets and yoyo‐effect, smoking cessation, and alcoholism. Other associated conditions include mental factors such as chronic stress or binge‐eating disorder and depression.Identifying and optimizing the underlying diseases, contributing factors, and other associated conditions may not only result in more effective and personalized treatment but could also reduce the social stigma for patients with obesity.

[1]  P. Darbre Endocrine Disruptors and Obesity , 2017, Current Obesity Reports.

[2]  P. Chanson,et al.  Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials. , 2004, The Journal of clinical endocrinology and metabolism.

[3]  John P H Wilding,et al.  Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation , 2017, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[4]  V. Montori,et al.  The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. , 2008, The Journal of clinical endocrinology and metabolism.

[5]  M. Vaisman,et al.  Impact of 5 years of growth hormone replacement therapy on cardiovascular risk factors in growth hormone-deficient adults. , 2008, Metabolism: clinical and experimental.

[6]  S. O’Rahilly,et al.  Obesity due to melanocortin 4 receptor (MC4R) deficiency is associated with increased linear growth and final height, fasting hyperinsulinemia, and incompletely suppressed growth hormone secretion. , 2011, The Journal of clinical endocrinology and metabolism.

[7]  V. Menon,et al.  Psychiatric disorders and obesity: A review of association studies , 2017, Journal of postgraduate medicine.

[8]  Sanjay R. Patel,et al.  Short Sleep Duration and Weight Gain: A Systematic Review , 2008, Obesity.

[9]  M. St-Onge,et al.  Sleep disturbances, body fat distribution, food intake and/or energy expenditure: pathophysiological aspects , 2014, Hormone molecular biology and clinical investigation.

[10]  L. Berglund,et al.  HIV protease inhibitors and obesity. , 2010, Current opinion in endocrinology, diabetes, and obesity.

[11]  Joshua A. Salomon,et al.  Health Effects of Overweight and Obesity in 195 Countries over 25 Years. , 2017, The New England journal of medicine.

[12]  I. Lindberg,et al.  PCSK1 Variants and Human Obesity. , 2016, Progress in molecular biology and translational science.

[13]  F. J. McClernon,et al.  Adverse childhood events are associated with obesity and disordered eating: results from a U.S. population-based survey of young adults. , 2009, Journal of traumatic stress.

[14]  G. Finlayson,et al.  Associations among sedentary and active behaviours, body fat and appetite dysregulation: investigating the myth of physical inactivity and obesity , 2016, British Journal of Sports Medicine.

[15]  C. Tek,et al.  Association of Prescription H1 Antihistamine Use With Obesity: Results From the National Health and Nutrition Examination Survey , 2010, Obesity.

[16]  Tim Cheetham,et al.  Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. , 2003, The New England journal of medicine.

[17]  A. Shechter Obstructive sleep apnea and energy balance regulation: A systematic review. , 2017, Sleep medicine reviews.

[18]  G. Austin,et al.  Association of Proton Pump Inhibitor (PPI) Use with Energy Intake, Physical Activity, and Weight Gain , 2015, Nutrients.

[19]  M Hassan Murad,et al.  Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. , 2017, The Journal of clinical endocrinology and metabolism.

[20]  R. Andridge,et al.  Depression, Daily Stressors, and Inflammatory Responses to High-Fat Meals: When Stress Overrides Healthier Food Choices , 2016, Molecular Psychiatry.

[21]  A. Vaag,et al.  Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis. , 2014, CMAJ open.

[22]  G. Doros,et al.  Effects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I-III: observational data from two registry studies , 2015, International Journal of Obesity.

[23]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[24]  A. Grüters,et al.  Mutations in the Human Proopiomelanocortin Gene , 2003, Annals of the New York Academy of Sciences.

[25]  T. Pischon,et al.  Hypothesis: Beta-adrenergic receptor blockers and weight gain: A systematic analysis. , 2001, Hypertension.

[26]  M. Yosef,et al.  Changes in body composition in women over six years at midlife: ovarian and chronological aging. , 2007, The Journal of clinical endocrinology and metabolism.

[27]  I. Benseñor,et al.  Effects of CPAP on body weight in patients with obstructive sleep apnoea: a meta-analysis of randomised trials , 2014, Thorax.

[28]  O. Franco,et al.  Associations Between Systemic and Local Corticosteroid Use With Metabolic Syndrome and Body Mass Index , 2017, The Journal of clinical endocrinology and metabolism.

[29]  M. Dallman Stress-induced obesity and the emotional nervous system , 2010, Trends in Endocrinology & Metabolism.

[30]  S. McClave,et al.  Common Medications Which Lead to Unintended Alterations in Weight Gain or Organ Lipotoxicity , 2015, Current Gastroenterology Reports.

[31]  E. Overton,et al.  Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence , 2016, Current HIV/AIDS Reports.

[32]  J. Levine,et al.  Nonexercise activity thermogenesis in obesity management. , 2015, Mayo Clinic proceedings.

[33]  Michael D. Jensen,et al.  Reprint: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. , 2013, Journal of the American Pharmacists Association : JAPhA.

[34]  Z. Hochberg,et al.  Hypothalamic obesity in children , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[35]  A. Rapaport,et al.  Weight Gain, Increased Appetite, and Excessive Food Intake Induced by Carbamazepine , 1991, Clinical neuropharmacology.

[36]  C. Tudor-Locke,et al.  Birth weight and childhood obesity: a 12-country study. , 2015, International journal of obesity supplements.

[37]  H. Bays,et al.  Adiposopathy and epigenetics: an introduction to obesity as a transgenerational disease , 2015, Current medical research and opinion.

[38]  M. Lupo,et al.  16p11.2 microdeletion syndrome: a case report , 2018, Journal of Medical Case Reports.

[39]  R. Kessler,et al.  The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication , 2007, Biological Psychiatry.

[40]  W. K. Simmons,et al.  Depression and obesity: evidence of shared biological mechanisms , 2018, Molecular Psychiatry.

[41]  K. Clément,et al.  Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist. , 2016, The New England journal of medicine.

[42]  P. Cuijpers,et al.  Depression and obesity: A meta-analysis of community-based studies , 2010, Psychiatry Research.

[43]  D. J. Driscoll,et al.  Prader-Willi syndrome. , 2009, European journal of human genetics : EJHG.

[44]  Janet B McGill,et al.  Body weight changes with beta-blocker use: results from GEMINI. , 2007, The American journal of medicine.

[45]  Robert A. Phillips,et al.  Body Weight Changes with β-Blocker Use: Results from GEMINI , 2007 .

[46]  Luca Busetto,et al.  European Guidelines for Obesity Management in Adults , 2015, Obesity Facts.

[47]  I. Farooqi The severely obese patient—a genetic work-up , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[48]  D. Allison,et al.  Antipsychotic-induced weight gain: a review of the literature. , 2001, The Journal of clinical psychiatry.

[49]  De-kun Li,et al.  Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study. , 2017, The lancet. Diabetes & endocrinology.

[50]  Robert F Kushner,et al.  2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. , 2014, Journal of the American College of Cardiology.

[51]  Paul W. Franks,et al.  Energy balance and obesity: what are the main drivers? , 2017, Cancer Causes & Control.

[52]  C. Haldeman-Englert,et al.  Disorders of GNAS Inactivation , 2017 .

[53]  Spain,et al.  Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. , 2007, The New England journal of medicine.

[54]  K. Carpenter,et al.  The effect of tobacco cessation on weight gain, obesity, and diabetes risk , 2016, Obesity.

[55]  G. Forti,et al.  Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. , 2013, European journal of endocrinology.

[56]  I. Hodish Insulin therapy, weight gain and prognosis , 2018, Diabetes, obesity & metabolism.

[57]  Marisa C. Moreta,et al.  Sleep deprivation potentiates HPA axis stress reactivity in healthy adults. , 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[58]  H. Meijers-Heijboer,et al.  Genetic obesity: next-generation sequencing results of 1230 patients with obesity , 2018, Journal of Medical Genetics.

[59]  A. McHill,et al.  Role of sleep and circadian disruption on energy expenditure and in metabolic predisposition to human obesity and metabolic disease , 2017, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[60]  P. Laurberg,et al.  Thyroid Function and Obesity , 2012, European Thyroid Journal.

[61]  T. Wadden,et al.  Evidence for prospective associations among depression and obesity in population‐based studies , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[62]  Jeffrey R Curtis,et al.  Population-based assessment of adverse events associated with long-term glucocorticoid use. , 2006, Arthritis and rheumatism.

[63]  D. Schoeller,et al.  Why do obese patients not lose more weight when treated with low-calorie diets? A mechanistic perspective. , 2007, The American journal of clinical nutrition.

[64]  Mami Matsushita,et al.  Recruited brown adipose tissue as an antiobesity agent in humans. , 2013, The Journal of clinical investigation.

[65]  M. Nieuwdorp,et al.  Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction. , 2017, Gastroenterology.

[66]  A. Shechter Effects of continuous positive airway pressure on energy balance regulation: a systematic review , 2016, European Respiratory Journal.

[67]  C. Shively,et al.  Chronic stress, metabolism, and metabolic syndrome , 2011, Stress.

[68]  A. Silman,et al.  Identification of late-onset hypogonadism in middle-aged and elderly men. , 2010, The New England journal of medicine.

[69]  K. Clément,et al.  Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016 , 2016, Obesity Facts.

[70]  B. Biondi,et al.  Thyroid and obesity: an intriguing relationship. , 2010, The Journal of clinical endocrinology and metabolism.

[71]  J. Sowers,et al.  Nebivolol in Obese and Non‐Obese Hypertensive Patients , 2009, Journal of clinical hypertension.

[72]  E. K. Ward,et al.  Acid suppression medications are associated with suboptimal weight loss after laparoscopic Roux-en-Y gastric bypass in patients older than 40 years. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[73]  O. Dekkers,et al.  [Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis]. , 2015, Nederlands tijdschrift voor geneeskunde.

[74]  Ngianga-Bakwin Kandala,et al.  Meta-analysis of short sleep duration and obesity in children and adults. , 2008, Sleep.

[75]  Arya M. Sharma,et al.  Obesity is a sign – over‐eating is a symptom: an aetiological framework for the assessment and management of obesity , 2010, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[76]  M. Wabitsch,et al.  Prevalence and phenotypic characterization of MC4R variants in a large pediatric cohort , 2017, International Journal of Obesity.

[77]  M. Butler,et al.  Prader-Willi syndrome: consensus diagnostic criteria. , 1993, Pediatrics.

[78]  P. Delhanty,et al.  The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options , 2014, International Journal of Obesity.

[79]  K. Channer,et al.  Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. , 2006, European journal of endocrinology.

[80]  C. Apovian,et al.  Pharmacological management of obesity: an endocrine Society clinical practice guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[81]  E. Gunderson Childbearing and obesity in women: weight before, during, and after pregnancy. , 2009, Obstetrics and gynecology clinics of North America.

[82]  F. Friedenberg,et al.  Genetic Associations of Obesity: The Fat-Mass and Obesity-Associated (FTO) Gene , 2016, Clinical and Translational Gastroenterology.

[83]  A. Serretti,et al.  Antidepressants and body weight: a comprehensive review and meta-analysis. , 2010, The Journal of clinical psychiatry.

[84]  F. de Jong,et al.  Shift work at young age is associated with elevated long-term cortisol levels and body mass index. , 2011, The Journal of clinical endocrinology and metabolism.

[85]  B. Penninx,et al.  Systematic Evaluation of Corticosteroid Use in Obese and Non-obese Individuals: A Multi-cohort Study , 2017, International journal of medical sciences.

[86]  M. Gulliford,et al.  Antidepressant utilisation and incidence of weight gain during 10 years’ follow-up: population based cohort study , 2018, British Medical Journal.

[87]  Mounir Chennaoui,et al.  Sleep debt and obesity , 2014, Annals of medicine.

[88]  E. V. van Rossum,et al.  Stress and Obesity: Are There More Susceptible Individuals? , 2018, Current Obesity Reports.

[89]  C. Correll,et al.  Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents. , 2011, Journal of child and adolescent psychopharmacology.

[90]  D. Sanyal,et al.  Hypothyroidism and obesity: An intriguing link , 2016, Indian journal of endocrinology and metabolism.

[91]  P. Chedraui,et al.  Understanding weight gain at menopause , 2012, Climacteric : the journal of the International Menopause Society.

[92]  K. Schulz,et al.  Combination contraceptives: effects on weight. , 2011, The Cochrane database of systematic reviews.

[93]  W. Chung,et al.  16p11.2 Recurrent Microdeletion , 2015 .

[94]  P. Beales,et al.  Bardet–Biedl syndrome , 2012, European Journal of Human Genetics.

[95]  J. Lebl,et al.  Treatment options for children with monogenic forms of obesity. , 2013, World review of nutrition and dietetics.

[96]  K. Kume,et al.  Long-term treatment with proton pump inhibitor is associated with undesired weight gain. , 2009, World journal of gastroenterology.

[97]  B. Psaty,et al.  A Review of the Adverse Effects of Peripheral Alpha-1 Antagonists in Hypertension Therapy , 2002, Current Controlled Trials in Cardiovascular Medicine.

[98]  D. Allison,et al.  Prescription medications: a modifiable contributor to obesity. , 1999, Southern medical journal.

[99]  T. Reinehr,et al.  Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. , 2006, The Journal of clinical endocrinology and metabolism.

[100]  R. Plodkowski,et al.  AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[101]  M. Macht How emotions affect eating: A five-way model , 2008, Appetite.

[102]  J. Korner,et al.  Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans , 2008, Pituitary.

[103]  M. Vance,et al.  Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[104]  M. Murad,et al.  Response to Letter: "Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline". , 2017, The Journal of clinical endocrinology and metabolism.

[105]  T. Pischon,et al.  Hypothesis: β-Adrenergic Receptor Blockers and Weight Gain , 2001 .

[106]  Q. Lu,et al.  Human Adenovirus 36 Infection Increased the Risk of Obesity , 2015, Medicine.

[107]  M Cutolo,et al.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data , 2005, Annals of the rheumatic diseases.

[108]  T. Friedman,et al.  Metabolic effects of smoking cessation , 2016, Nature Reviews Endocrinology.

[109]  R. Brook,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Journal of the American Society of Hypertension : JASH.

[110]  So Hun Kim,et al.  Brown Fat and Browning for the Treatment of Obesity and Related Metabolic Disorders , 2016, Diabetes & metabolism journal.

[111]  E. van Cauter,et al.  Disturbances of sleep and circadian rhythms: novel risk factors for obesity , 2016, Current opinion in endocrinology, diabetes, and obesity.

[112]  B. Kulseng,et al.  Timeline of changes in adaptive physiological responses, at the level of energy expenditure, with progressive weight loss , 2018, British Journal of Nutrition.

[113]  C. Lewis,et al.  Childbearing May Increase Visceral Adipose Tissue Independent of Overall Increase in Body Fat , 2008, Obesity.

[114]  A. Janet Tomiyama,et al.  Weight stigma is stressful. A review of evidence for the Cyclic Obesity/Weight-Based Stigma model , 2014, Appetite.